JP2003159194A - Wet tissue for clearing anus - Google Patents

Abstract

<P>PROBLEM TO BE SOLVED: To provide wet tissue which is higher in safety, has obstruction action of various kinds of enzymes to be excellent in effect of suppressing a rash such as a diaper rash, etc., and has no economic problem. <P>SOLUTION: This wet tissue paper is produced by impregnating aqueous chemical solution into a tissue paper substrate. The wet tissue paper contains an eucalyptus extract by 0.001-1.0 mass% as solid. When 1-12 mass% of polyalcohol as a moisture keeping agent and 0.01-0.4 mass% of paraoxybenzoic acid as a mildewproof agent are contained, the effect is further improved. <P>COPYRIGHT: (C)2003,JPO

Description

Detailed Description of the Invention

[0001]

TECHNICAL FIELD The present invention relates to a wet wipe for wipes used for adults, babies and the like.

[0002]

2. Description of the Related Art Wet wipe wipe tissues (hereinafter referred to as "wet tissues") are used, for example, to remove excrement adhering to the skin and keep the skin clean after using the diaper. On the other hand, when using a diaper, for example, dermatitis such as diaper rash may occur due to the effects of harmful components such as urine and feces and enzymes contained in the excrement,
This is a problem because a bad odor is generated by the action of microorganisms. Therefore, for example, it is possible to prevent or mitigate the above problems if the wet tissue is added with effects such as diaper rash suppression, inflammation suppression, antibacterial and deodorizing and the effect can be maintained when used on the human body. It is believed that there is. Since the components contained in the wet tissue come into contact with the skin of the human body, those having high safety are desired.

As an example of adding a function to a wet tissue, a wet tissue for sterilization containing hypochlorous acid (JP-A-9-173427) and a wet tissue for disinfection / sterilization containing benzalkonium chloride (special (Kaihei 8-164191), a wet tissue containing bamboo dry distillate as a cleaning agent (JP-A-9-8712).
3), phenoxyethanol, grape leaf extract, etc. as a fungicide / antifungal component and a deodorant component (JP 2001-206818 A) and the like have been reported. Further, Japanese Patent Application Laid-Open No. 12-154 by the present applicant
Japanese Patent Laid-Open No. 109 discloses a bactericidal agent in which a Eucalyptus plant extract and chitosan are used in combination, and it is described that the bactericidal agent exerts a bactericidal action when applied to a wet tissue.

[0004]

However, it is presumed that enzymes such as urease and trypsin are also involved in diaper rash, and in order to prevent diaper rash, a bactericidal agent, a deammonifying agent, etc. are simply used. However, it is necessary to consider the inhibitory action of various enzymes. Therefore, an object of the present invention is to provide a wet tissue that is highly safe, has an excellent effect of suppressing a rash such as a diaper rash, and has no problem in terms of economical efficiency.

[0005]

In order to solve the above problems, the present invention adopts the following configurations. That is, the first aspect of the present invention is that, in a wet tissue in which a tissue paper base material is impregnated with an aqueous chemical solution, the Eucalyptus extract is 0.001% by mass to 1.0% by mass based on the dry mass of the base material.
It is a wet tissue for wipes characterized by containing it in a mass%.

A second aspect of the present invention is the same as the first aspect.
Eucalyptus extract as a solid content of 0.
The wet tissue for wipes is characterized by containing 02 mass% to 0.125 mass%.

A third aspect of the present invention is the first or second aspect of the invention.
In the invention, the wet wipes wipes wipes are characterized in that the concentration of ethanol contained in the chemical solution of the wet wipes wipes is 0 to 15% by mass.

A fourth aspect of the present invention is the same as the first to third aspects, wherein the chemical liquid contains 1 to 1 polyhydric alcohol as a moisturizing agent.
The wet tissue for wipes according to any one of claims 1 to 3, which contains 12% by mass and 0.01 to 0.4% by mass of paraoxybenzoic acids as a mildew-proofing agent.

As a result of intensive studies for solving the above-mentioned problems, the present inventors have found that a wet tissue containing a specific amount of eucalyptus extract has an excellent effect of preventing diaper rash, has high safety and is most suitable for wipes. The inventors have found out that, and have reached the present invention.

[0010]

BEST MODE FOR CARRYING OUT THE INVENTION The wet tissue for wipes of the present invention is a wet tissue obtained by impregnating a tissue paper base material with an aqueous chemical solution, and the chemical solution dissolves components such as a moisturizer and a mildewproofing agent in water or It is a dispersed aqueous liquid.

The structure of the present invention will be described in detail below. The raw material of the eucalyptus extract used in the present invention is not particularly limited as long as it is a plant of the genus Eucalyptus of the family Myrtaceae, E. g
lobulus , E. viminalis , E. camaldulensis , E. grandi
s , E. nitens . Moreover, as a Eucalyptus plant, it can be used individually or in combination of 2 or more types. The site of the plant used for producing the eucalyptus extract is not particularly limited, but branches and leaves that are easily collected are preferable, and leaves are particularly preferable.

The eucalyptus extract described in the present invention is an extract obtained by extracting eucalyptus leaves, branches and the like with a polar solvent. Examples of the polar solvent used for extraction include alcohols, glycols, ketones, esters, ethers, halogenated carbons and the like. Examples of lower alcohols include ethanol, methanol, propanol and the like. Examples of glycols include ethylene glycol, diethylene glycol, butylene glycol and propylene glycol. Examples of the ketones include acetone and methyl ethyl ketone, and examples of the esters include ethyl acetate, propyl acetate, ethyl formate and the like. These solvents may be used alone or as an aqueous solution, or may be used as a mixed solvent of any two kinds or three kinds or more. Among the above solvents, ethanol, butylene glycol and propylene glycol are more preferable.

The Eucalyptus extract may be extracted by, for example, immersing Eucalyptus leaves in an extraction solvent, heating at a temperature not higher than the boiling point of the solvent, performing extraction with stirring, and filtering to obtain an extract. There is a method. The leaves used for extraction may be dry leaves or may contain water, but in order to obtain highly effective extracts, it is desirable to use dry leaves. In addition, the leaves may be pretreated so as to be easily extracted with a solvent, for example, by pulverizing the leaves into an appropriate size or pulverizing the leaves. or,
In order to reduce the odor, color, etc. of the extract, the leaves may be subjected to a pretreatment such as washing with water or immersion in hot water before being immersed in the extraction solvent.

In order to obtain a eucalyptus extract having a higher anti-rash effect during the above extraction operation, a method of directly extracting eucalyptus leaves with lower alcohols or glycols is desirable. Ethanol is desirable as the lower alcohol, and butylene glycol as the glycols,
Propylene glycol is preferred.

It is also possible to dry the eucalyptus leaves, degrease them with a non-polar organic solvent to remove the essential oil, and then extract with lower alcohols or glycols. This operation can also be carried out by a method in which the essential oil is removed by steam distillation, and then a lower alcohol or glycol is added to the residue for extraction. As the non-polar solvent, hexane, pentane,
Examples include alkanes such as heptane.

The eucalyptus extract can be used as it is, but the extract can also be used after removing the color and odor using an appropriate adsorbent or clathrate. Examples of the adsorbent include activated carbon, Celite, silica gel, diatomaceous earth and zeolite. Examples of the clathrate include cyclodextrin and cellulose.

Further, the obtained Eucalyptus extract is further fractionated into highly effective fractions by an appropriate separation means such as partition extraction, gel filtration, silica gel chromatography or reversed phase or normal phase high performance liquid chromatography. You can also use it.

The Eucalyptus extract obtained by the above operation is preferably dissolved in a mixed solvent of water and lower alcohol or a mixed solvent of water and butylene glycol before use.

The eucalyptus extract used in the present invention preferably has inhibitory activity against trypsin, urease and the like which are enzymes involved in diaper rash.

When the above extract is used for the purpose of suppressing diaper rash, various components, moisturizers and acidity regulators commonly used in pharmaceuticals, quasi drugs, cosmetics, etc., within the range not impairing the effects of the present invention. , Stabilizers, surfactants, antioxidants, deodorants, antibacterial agents, antifungal agents, etc. can be blended, and these auxiliary ingredients can be blended with two or more ingredients. good.

Various ingredients generally used in medicines, quasi drugs, cosmetics and the like include allergy suppressants, atopic dermatitis suppressors, itch suppressors, skin roughening suppressors, lower alcohols, polyhydric alcohols, and fragrances. , A cooling agent, an animal and plant polysaccharide and its degradation product, an animal and plant glycoprotein and its degradation product, a microbial culture metabolic component, an amino acid and its salt, a deodorant, an emulsifier and the like, and they can be used in combination.

The moisturizers include aloe extract, proliferating herb extract, hypericum extract, barley extract, orange extract, seaweed extract, chamomile extract, cucumber extract, comfrey extract, burdock extract, shiitake extract, perilla extract, perilla extract, sage extract, Duke extract, Cordyceps sinensis extract, Dokudami extract, Hatake shimeji extract, loquat extract, grape leaf extract, fuyubodaiju extract, prune extract, loofah extract, button pi extract, makai extract, momoha extract, lily extract, apple extract, almond oil, olive oil, sesame oil, safflower Oil, dimethyl silicone, silicone oil, modified silicone, soybean oil, camellia oil, castor oil, jojoba oil, mink oil, coconut oil, lanolin, arabinose, galactose, xylose, Glucose, sucrose, sorbitol, fructose, maltose, maltitol, mannose, beeswax, hyaluronic acid, placenta extract,
Rhamnose, xylobiose, xylooligosaccharide, tuberose polysaccharide, trisaccharide, trehalose, soluble collagen, glycyrrhizin, chondroitin sulfate, diglycerin, squalane, ceramide-like compound, triglycerin, urea, vitamin C phosphate ester calcium salt, vitamin E, pyrrolidone Examples thereof include sodium carboxylate, hinokitiol, liquid paraffin, petrolatum and polyhydric alcohol.

Among these moisturizers, aloe extract, prolong life herb extract, hypericum extract, comfrey extract,
Perilla extract, sage extract, ceramide-like compound, Dokudami extract, Hatake shimeji extract, loquat extract, Fujudaiju extract, button pi extract, castor oil, jojoba oil, lanolin, hyaluronic acid, placenta extract, rhamnose, xylooligosaccharide, soluble collagen, glycerin, chondroitin Sulfuric acid, squalane, urea and polyhydric alcohol have a high moisturizing effect on the skin and can be more preferably used. As the polyhydric alcohol, ethylene glycol, glycerin, 1,3-butylene glycol, propylene glycol and the like are preferable. Among them, aloe extract,
Xylo-oligosaccharides, ceramide-like compounds, edible mushroom extract, urea, 1,3-butylene glycol and propylene glycol are particularly preferred. From the viewpoint of the effect, it is preferable that these moisturizing agents be contained in the chemical solution in the range of 1 to 12 mass%.

The acidity regulator and the function stabilizer include:
For example, adipic acid, citric acid, trisodium citrate, glycine, glycerin fatty acid ester, gluconodelta lactone, gluconic acid, succinic acid, monosodium succinate, disodium succinate, acetic acid, sodium acetate, DL-tartaric acid, L -Tartaric acid, DL-sodium tartrate, L-sodium tartrate, carbonates, carbon dioxide, lactic acid, sodium lactate, fumaric acid, monosodium fumarate, lysozyme, DL-malic acid, DL-sodium malate, phosphoric acid, phosphoric acid Examples thereof include salts, polymerized phosphates, itaconic acid, phytic acid and the like.

Examples of the surfactant include glycerol fatty acid esters such as glycerol monostearate and polyglycerol trioleate, organic acid monoglycerides,
Propylene glycol fatty acid ester, sorbitan fatty acid ester, sucrose fatty acid ester, lecithin, lysolecithin, polyethylene glycol, polyoxyalkyl ether, polyoxyethylene polyamine, alkyl polyoxyethylene sulfuric acid ester salt, alkyl sulfuric acid ester salt, acylmethyl taurine salt, N -Acyl glutamate, alkylamido betaine and the like can be mentioned.

Examples of antioxidants include catechin, tocopherol, propolis, ellagic acid, and plant extracts (sage, seri, rosemary, etc.).

The deodorant is not particularly limited as long as it is a substance or an extract having a deodorant activity, and examples thereof include extracts of plants and mushrooms, essential oils and the like.

The antibacterial agent is not particularly limited as long as it is a substance or extract having antibacterial activity, and examples thereof include hinokitiol, triclosan, cetylpyridinium chloride, chlorhexidine gluconate and the like.

Examples of the fungicide include potassium sorbate, sorbic acid, sodium benzoate, benzoic acid, ethyl paraoxybenzoate, methyl paraoxybenzoate, paraoxybenzoic acid such as propyl paraoxybenzoate, animals and the like.
Examples include plant extracts and essential oils. These fungicides are
From the viewpoint of the effect, it is preferable to set it in the range of 0.01 to 0.4 mass% in the chemical solution.

The wet tissue of the present invention can be obtained by incorporating the above-obtained eucalyptus extract or the composition containing the eucalyptus extract into a wet tissue.

By using the wet tissue of the present invention, it is possible to prevent or reduce diaper rash caused by harmful components contained in urine and feces, enzymes and the like.

Regarding the wet tissue of the present invention,
Known materials can be used without particular limitation, but the materials used in the present invention will be specifically described below.

The wet tissue can be manufactured by impregnating a conventionally known wet tissue base material with a chemical solution using a conventionally known external addition method. As the conventionally known wet tissue base material, for example, one or more kinds of fibers such as pulp, rayon, polyester, and acrylic are used, and a non-woven fabric manufactured by a conventionally known manufacturing method such as a wet method, a dry method, an air ray method. It is possible to use a sheet base material such as paper or paper, or a sheet obtained by combining them. Hereinafter, this base material is referred to as a tissue paper base material. Tissue paper has a surface area of 20-60
g / m ² is the range that is easy to use.

The wet tissue of the present invention is produced by impregnating a tissue paper base material with a chemical solution containing eucalyptus extract. Alternatively, the tissue paper base material may be manufactured by impregnating a specific amount of the eucalyptus extract and then impregnating the chemical liquid, or after impregnating the tissue paper base material with the chemical liquid and adding the eucalyptus extract. it can. Hereinafter, the chemical solution is also referred to as an impregnating solution.

As a method for producing the wet tissue impregnating liquid, a conventionally known impregnating liquid can be used. For example, the eucalyptus extract may be diluted with purified water to obtain an impregnating solution, and in addition to the eucalyptus extract, alcohols such as propylene glycol and ethanol, parabens, benzalkonium chloride, antifungal agents such as benzoate, etc. It is also possible to use an impregnating liquid prepared by mixing one kind or a plurality of kinds of the above-mentioned auxiliary components in a desired concentration.

Furthermore, the order of addition of eucalyptus extract to the impregnating liquid, the amount of the eucalyptus extract, and the like can be arbitrarily determined within the range of the amount shown in the present invention, and the impregnating liquid containing no eucalyptus extract can be used as a wet tissue. After impregnation, a predetermined amount of eucalyptus extract may be applied by an impregnation method, a spray method, or the like.

As an example of the external addition method, for example, a treatment liquid containing eucalyptus extract is sprayed on a sheet, a treatment liquid containing eucalyptus extract is applied by a gravure printing roll, or a sheet is dipped in the treatment liquid. And the like. These may be processed online in the sheet manufacturing line, or may be applied offline after the sheet is manufactured.

In the wet tissue of the present invention, the desired effect can be obtained if the wet tissue base material or the wet tissue impregnating solution contains a specific amount of the eucalyptus extract. Generally, the amount of the wet tissue impregnating liquid impregnated into the wet tissue base material is 50% by mass to 500% by mass with respect to the mass of the tissue paper base material,
It is preferably 150 to 300% by mass, but whichever method is used, when the base material is impregnated with the wet tissue impregnating liquid, the eucalyptus extract is contained in each of the impregnating liquids in the sheet and between the sheets. It exists in a dispersed state, and it is possible to give an effect when used.

In the present invention, the amount of the eucalyptus extract added to the wet tissue may be in the range of 0.001% by mass to 1.0% by mass based on the dry weight of the tissue paper substrate, but 0.02% 0.125 mass% is preferable.
If the amount is less than 0.001% by mass, the effect is not clearly exhibited, and if the amount added exceeds 0.125% by mass, the color and odor of the eucalyptus extract gradually affect, so the color and odor are reduced. As an operation for removing, for example, pretreatment such as activated carbon treatment is required. Further, if it exceeds 1.0 mass%, it is not preferable in terms of manufacturing cost.

In the present invention, the concentration of ethanol contained in the chemical solution of the wet tissue is preferably 0 to 15% by mass, more preferably 0 to 5% by mass.

[0041]

EXAMPLES The present invention will be described in detail below based on examples and comparative examples. The present invention is not limited to this. The method for preparing the eucalyptus extract used in the examples is shown below.

<Production Example 1> Eucalyptus globu
50 g of leaves of lus ) were extracted with 50% ethanol (600 ml) for 3 days at room temperature to obtain an extract. These extracts were concentrated under reduced pressure to obtain 0.975 g of the extract (1.
95 mass%) was obtained. Hereinafter, this is referred to as Extract 1.

<Production Example 2> Eucalyptus globu
50 g of leaves of lus ) was extracted with 50% by volume of 1,3-butylene glycol (550 ml) for 3 days at room temperature to obtain an extract (solid content 2.10%). 50% by volume of this extract
The solid content of the extract was 1,3-butylene glycol
It was prepared to be 2.0% (2.0 g / 100 cc) and used as Extract 2.

<Example 1> The content of the extract 1 obtained in Production Example 1 was 1. Tg of a tissue paper base material (area weight: 40 g / m ² ).
Example 1 was prepared by uniformly spraying the following chemicals onto a 100 g / m ² base material so as to be 0% by mass to prepare a wet tissue. Chemical composition: 0.4 g of Extract 1, 2 g of ethanol, 5 g of propylene glycol and 0.15 g of ethyl benzoate were added to about 93 g of distilled water to obtain 100 g of a chemical solution.

Example 2 The same chemical solution as in Example 1 was sprayed onto the substrate in the same manner as in Example 1 so that the content of the extract 1 was 0.125% by mass of the tissue paper substrate. A wet tissue was prepared and used as Example 2. However, the mass of the extract 1 added to the drug solution was changed to 0.05 g.

<Example 3> Example 1 was prepared so that the content of the extract 1 was 0.02% by mass of the tissue paper base material.
The same chemical solution as in Example 1 was sprayed on the substrate in the same manner as in Example 1,
A wet tissue was prepared and used as Example 3. However,
The mass of Extract 1 added to the drug solution was changed to 0.008 g.

Example 4 The same chemical solution as in Example 1 was sprayed on the substrate in the same manner as in Example 1 so that the content of the extract 1 was 0.001% by mass of the tissue paper substrate. A wet tissue was prepared and used as Example 4. However, the mass of Extract 1 added to the drug solution was changed to 0.0004 g.

<Comparative Example 1> A wet solution was prepared by spraying a wet solution onto a base material in the same manner as in Example 1 except that Extract 1 was not added to the chemical solution. It was set to 1.

Comparative Example 2 The same chemical solution as in Example 1 was sprayed onto the substrate in the same manner as in Example 1 so that the content of the extract 1 was 0.00025% by mass of the tissue paper substrate. A wet tissue was prepared and used as Example 3. However, the mass of Extract 1 added to the drug solution is 0.0001 g
Changed to.

User tests were performed on the wet tissues produced in Examples 1 to 4 and Comparative Examples 1 and 2 in the following manner.

Grouping users: baby 550
11 people (50 people each, average age 18 months)
Divided into groups.

Samples used in each group: Two types of wet tissues (A, B) were distributed to each group. Group 1 Sample A: Example 1, Sample B: Comparative Example 1 Group 2 Sample A: Comparative Example 1, Sample B: Example 1 Group 3 Sample A: Example 2, Sample B: Comparative Example 1 Group 4 Sample A: Comparative Example 1, Sample B: Example 2 Group 5 Sample A: Example 3, Sample B: Comparative Example 1 Group 6 Sample A: Comparative Example 1, Sample B: Example 3 Group 7 Sample A: Example 4, Sample B: Comparative Example 1 Group 8 Sample A: Comparative Example 1, Sample B: Example 4 Group 9 Sample A: Comparative Example 1, Sample B: Comparative Example 1 Group 10 Sample A: Comparative Example 2, Sample B: Comparative Example 1 Group 11 Sample A: Comparative Example 1, Sample B: Comparative Example 2

Comparative test method: 1 after each sample was wiped uniformly with the wet tissue of sample A
They asked me to use the diaper for 0 days, then switched to sample B and wiped my ass evenly, and then used the diaper for 10 days. In addition, every time the diaper was changed, the wipe was wiped with a wet tissue. Mothers received comparative answers about the likelihood of diaper rash. It was determined that there was a difference in the feeling of use when the ratio of the number of people who were determined to be less likely to have a rash was twice or more as compared with Sample A and Sample B. Further, when the number of people who were judged to be less likely to have a rash exceeded the number of people who did not change, it was determined that the effect on the rash was sufficiently exhibited. The results are shown in Table 1.
Shown in.

[0054]

[Table 1]

In Groups 9 to 11 (Comparative Examples 1 and 2), no clear difference in rash resistance was found between Sample A and Sample B. Groups 1-8 (Example 1
In Examples 4 to 4, although there is some difference between the groups, Examples 1 to 4 were evaluated to be less prone to rash in any of the groups. In addition, groups 1 to 6 (Example 1)
3 to 3) were more effective than the groups 7 and 8 (Example 4). From the above results, it is confirmed that when the wet tissue containing the eucalyptus extract in an amount of 0.001 to 1.0 mass% with respect to the wet tissue base material is wiped on the buttocks, the occurrence of diaper rash is suppressed, .02
The effect was high at ˜1.0% by mass.

<Example 5> The Eucalyptus extract content of the extract 2 obtained in Production Example 2 was found to be a tissue paper substrate (Basis weight 4
0 g / m ² ).
A wet tissue was prepared by spraying the g / m ² base material evenly by spraying, and this was taken as Example 5. Chemical composition: 20 ml of extract 2 (liquid) and 0.15 g of ethyl benzoate were added to about 80 g of distilled water to obtain 100 g of a chemical solution.

<Example 6> The following chemical solution (10 g of 1,3-butylene glycol) was added so that the content of the eucalyptus extract of Extract 2 was 0.125% by mass of the tissue paper base material.
/ 100 ml) was sprayed on the substrate in the same manner as in Example 5 to prepare a wet tissue, which was referred to as Example 6. Chemical composition: Extract 2 2.5 ml (liquid), 1,3-butylene glycol 8.75 g, ethyl benzoate 0.15 g
Was added to about 88.75 g of distilled water to obtain 100 g of a drug solution.

<Example 7> The following chemical solution (10 g of 1,3-butylene glycol / 10 g / liter) was added so that the content of the eucalyptus extract of the extract 2 was 0.02% by mass of the tissue paper base material.
(Including 100 ml) was sprayed on the substrate in the same manner as in Example 5 to prepare a wet tissue, which was referred to as Example 7. Chemical composition: 0.4 ml of Extract 2 (liquid), 9.8 g of 1,3-butylene glycol and 0.15 g of ethyl benzoate were added to about 89.8 g of distilled water to obtain 100 g of a chemical solution.

<Example 8> The following chemical solution (10 g of 1,3-butylene glycol) was added so that the content of the eucalyptus extract of the extract 2 was 0.001% by mass of the tissue paper base material.
/ 100 ml) was sprayed on the substrate in the same manner as in Example 5 to prepare a wet tissue, which was referred to as Example 8. Chemical composition: Extract 2 0.02 ml (liquid), 1,3-butylene glycol 9.99 g, ethyl benzoate 0.15
g was added to about 89.99 g of distilled water to obtain 100 g of the drug solution.

Comparative Example 1 A eucalyptus extract-free drug solution (1,3-butylene glycol 10 g / 1) was prepared in the same manner as in Example 5 except that Extract 2 was not added to the drug solution.
(Including 100 ml) was sprayed on the substrate in the same manner as in Example 5 to prepare a wet tissue, which was used as Comparative Example 1.

<Comparative Example 3> The following chemical solution (1,3-butylene glycol 10) was added so that the content of the eucalyptus extract of the extract 2 was 0.0002% by mass of the tissue paper base material.
(including g / 100 ml) was sprayed on the base material in the same manner as in Example 5 to prepare a wet tissue, which was set as Comparative Example 3. Chemical composition: Extract 2 0.004 ml (liquid), 1,3-
Butylene glycol 9.998 g, ethyl benzoate 0.
15 g was added to about 89.998 g of distilled water to obtain 100 g of the drug solution.

User tests were conducted on the wet tissues produced in Examples 5 to 8 and Comparative Examples 1 and 3 in the following manner.

User grouping: baby 550
11 people (50 people each, average age 18 months)
Divided into groups.

Samples used for each group: Two types of wet tissues (A, B) were distributed to each group. Group 1 Sample A: Example 5, Sample B: Comparative Example 1 Group 2 Sample A: Comparative Example 1, Sample B: Example 5 Group 3 Sample A: Example 6, Sample B: Comparative Example 1 Group 4 Sample A: Comparative Example 1, Sample B: Example 6 Group 5 Sample A: Example 7, Sample B: Comparative Example 1 Group 6 Sample A: Comparative Example 1, Sample B: Example 7 Group 7 Sample A: Example 8, Sample B: Comparative Example 1 Group 8 Sample A: Comparative Example 1, Sample B: Example 8 Group 9 Sample A: Comparative Example 1, Sample B: Comparative Example 1 Group 10 Sample A: Comparative Example 3, Sample B: Comparative Example 1 Group 11 Sample A: Comparative Example 1, Sample B: Comparative Example 3

Comparative Test Method: The rash resistance was evaluated in the same manner as in Examples 1 to 4. The results are shown in Table 2.

[0066]

[Table 2]

In Groups 9 to 11 (Comparative Examples 1 and 2), no clear difference in rash resistance was found between Sample A and Sample B. Groups 1-8 (Example 5)
8 to 8), although there were some differences between the groups, it was evaluated that Examples 5 to 8 were less prone to rash in any of the groups. In addition, groups 1 to 6 (Example 5)
.About.7), the effect was higher than that of groups 7 and 8 (Example 8). From the above results, it is confirmed that when the wet tissue containing the eucalyptus extract in an amount of 0.001 to 1.0 mass% with respect to the wet tissue base material is wiped on the buttocks, the occurrence of diaper rash is suppressed, .0
The effect was high at 2 to 1.0 mass%.

[0068]

The wet tissue containing the eucalyptus extract obtained in the present invention is effective against diaper rash, rough skin and the like.

Claims (4)

[Claims] 1. A wet tissue obtained by impregnating a tissue paper base material with an aqueous chemical solution, wherein the Eucalyptus extract is contained in a solid content of 0.001% by mass to dry mass of the base material.
A wet tissue for wipes containing 1.0% by mass. 2. The wet tissue for wipes according to claim 1, wherein the eucalyptus extract is contained in a solid content of 0.02% by mass to 0.125% by mass with respect to the dry mass of the base material. 3. The wet tissue for wipes according to claim 1, wherein the concentration of ethanol contained in the chemical solution of the wet tissue for wipes is 0 to 15 mass%. 4. The chemical liquid contains 1 to 12% by mass of a polyhydric alcohol as a moisturizing agent and 0.01 to 0.4% by mass of a paraoxybenzoic acid compound as a mildew-proofing agent. The wet tissue for wipes according to any one of claims 1 to 3.